The Results Are In from Quest Diagnostics®
The Results Are In from Quest Diagnostics®
Podcast Description
Physicians routinely diagnose and treat acute and chronic conditions
across multiple clinical areas. Whether it’s a condition studied for
decades or an emerging infection, comprehensive diagnostic testing is
enabling faster and more effective care to drive better patient outcomes.
In fact, most medical decisions are based at least partly on lab testing!
On The Results Are In from Quest Diagnostics®, we are joined by
diagnostics industry leaders who support providers in optimizing care
pathways for their patients. From the latest in cutting-edge research to
the real-world impact of diagnostic testing on treatment journeys, The
Results Are In features can’t-miss stories for those wanting to stay in the
know about the latest innovations in laboratory diagnostics.
Podcast Insights
Content Themes
The podcast focuses on a variety of topics within the field of diagnostics, such as innovative lab testing techniques, the role of biomarkers in early detection of diseases like Alzheimer’s, and the impact of diagnostic choices on patient care. Episodes highlight case studies, like the integration of blood-based biomarkers for Alzheimer’s risk assessment, underscoring trends that shape healthcare delivery.
Physicians routinely diagnose and treat acute and chronic conditions
across multiple clinical areas. Whether it’s a condition studied for
decades or an emerging infection, comprehensive diagnostic testing is
enabling faster and more effective care to drive better patient outcomes.
In fact, most medical decisions are based at least partly on lab testing!
On The Results Are In from Quest Diagnostics®, we are joined by
diagnostics industry leaders who support providers in optimizing care
pathways for their patients. From the latest in cutting-edge research to
the real-world impact of diagnostic testing on treatment journeys, The
Results Are In features can’t-miss stories for those wanting to stay in the
know about the latest innovations in laboratory diagnostics.
Per- and polyfluoroalkyl substances (PFAS), often called “forever chemicals,” have made their way into drinking water, consumer products, and even our bodies. With potential health risks tied to exposure, PFAS have become one of the most pressing public health challenges today.
In this episode of The Results Are In from Quest Diagnostics, host Dr Jack Kain speaks with Dr. Sarah Bartock, National Science Director of Drug Monitoring & Toxicology at Quest. Together, they break down what PFAS are, how people are exposed, and the health conditions that have been linked to these chemicals. They also discuss how blood testing—including Quest’s PFAS 9 Panel—can help patients and providers better understand risk and make informed decisions about exposure reduction and health monitoring.
Listeners will also hear about emerging research into possible interventions, the limitations of current testing, and the broader challenges of addressing PFAS in the environment.
Don’t miss this important conversation that connects environmental science, preventive care, and clinical practice.
Follow Us
Twitter @QuestDX
Facebook @QuestDiagnostics
Instagram @QuestDiagnostics
LinkedIn @QuestDiagnostics
Abbreviations used in episode:
NHANES: National Health and Nutrition Examination Survey
NASEM: National Academies of Science, Engineering, and Medicine
References mentioned in episode:
- Møller JJ, Lyngberg AC, Hammer PEC, et al.. Substantial decrease of PFAS with anion exchange resin treatment – A clinical cross-over trial. Environ Int. 2024;185:108497. doi:10.1016/j.envint.2024.108497
- Ducatman A, Luster M, Fletcher T. Perfluoroalkyl substance excretion: Effects of organic anion-inhibiting and resin-binding drugs in a community setting. Environ Toxicol Pharmacol. 2021;85:103650. doi:10.1016/j.etap.2021.103650
- Lindell AE, Grießhammer A, Michaelis L, et al. Human gut bacteria bioaccumulate per- and polyfluoroalkyl substances. Nat Microbiol. 2025;10(7):1630-1647.
- Dzierlenga MW, Keast DR, Longnecker MP. The concentration of several perfluoroalkyl acids in serum appears to be reduced by dietary fiber. Environ Int. 2021;146:106292. doi:10.1016/j.envint.2020.106292
- Schlezinger JJ, Biswas K, Garcia A, Heiger-Bernays WJ, Bello D. An oat fiber intervention for reducing PFAS body burden: A pilot study in male C57Bl/6 J mice. Toxicol Appl Pharmacol. 2025;495:117188. doi:10.1016/j.taap.2024.117188
- Tian Y, Luan M, Zhang J, Yang H, Wang Y, Chen H. Associations of single and multiple perfluoroalkyl substances exposure with folate among adolescents in NHANES 2007-2010. Chemosphere. 2022;307(Pt 3):135995. doi:10.1016/j.chemosphere.2022.135995
- Zhang Y, Mustieles V, Wang YX, Sun Y, Agudelo J, et al.. Folate concentrations and serum perfluoroalkyl and polyfluoroalkyl substance concentrations in adolescents and adults in the USA (National Health and Nutrition Examination Study 2003-16): an observational study. Lancet Planet Health. 2023;7(6):e449-e458. doi:10.1016/S2542-5196(23)00088-8
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.